Status:
COMPLETED
Bright Light Therapy for Residual Daytime Symptoms Associated With Obstructive Sleep Apnea
Lead Sponsor:
VA Office of Research and Development
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
50-65 years
Phase:
NA
Brief Summary
Sleep apnea is one of the most common chronic condition among US military Veterans, causing sleepiness, reduced psychomotor vigilance and depression, which undermine daytime functioning and quality of...
Detailed Description
Due to COVID-19 pandemic emergency measures, recruitment for clinical trials is currently on hold Background: Sleep apnea is one of the most common chronic condition among US military Veterans , it c...
Eligibility Criteria
Inclusion
- Veterans from the VA Pittsburgh Healthcare System (VAPHS)
- Documented diagnosis of OSA
- Currently on CPAP or BiPAP with documented adherence (defined as wearing CPAP/BiPAP for \>4h/night on at least 75% of nights)
- Excessive residual daytime sleepiness (Epworth score \> 10)
- Endorsing depressive symptoms (Quick Inventory of Depressive Symptomatology (Self-Report) \[QIDS-SR\] score\>8)
Exclusion
- Shift work
- Travel across time zones in the past month
- Narcolepsy
- Congestive heart failure (CHF)
- Poorly controlled diabetes (HgA1c\>7%)
- Active substance use disorder
- Dementia
- Bipolar disorder
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 13 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04299009
Start Date
September 1 2020
End Date
September 13 2022
Last Update
February 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, Pennsylvania, United States, 15240